<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-1AUQ25W9</identifier><date>2020</date><creator>Cerović, Snežana</creator><creator>Drev, Primož</creator><creator>Gazić, Barbara</creator><creator>Hočevar, Marko</creator><creator>Perhavec, Andraž</creator><creator>Pospihalj, Boris</creator><creator>Zupančič, Marko</creator><relation>documents/doc/1/URN_NBN_SI_doc-1AUQ25W9_001.pdf</relation><relation>documents/doc/1/URN_NBN_SI_doc-1AUQ25W9_001.txt</relation><format format_type="issue">2</format><format format_type="volume">54</format><format format_type="type">article</format><format format_type="extent">str. 194-200, VII</format><identifier identifier_type="DOI">10.2478/raon-2020-0019</identifier><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">13549827</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-1AUQ25W9</identifier><language>eng</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">biokemija</subject><subject language_type_id="slv">nuklearni faktor kappa beta</subject><subject language_type_id="slv">prostata</subject><subject language_type_id="slv">rak (medicina)</subject><title>Significance of nuclear factor - kappa beta activation on prostate needle biopsy samples in the evaluation of Gleason score 6 prostatic carcinoma indolence</title></Record>